Skip to main content
. 2020 Jul 27;10:12472. doi: 10.1038/s41598-020-69416-x

Table 3.

IC50 values and tumor specificity index.

Compounds IC50 (µM) Tumor specificity index
HeLa* HT29* C6* Vero* HeLa HT29 C6
2 3.64 ± 0.42 0.87 ± 0.09 0.95 ± 0.09 2.81 ± 0.32 0.77 3.23 2.96
3 3.19 ± 0.37 2.37 ± 0.32 3.34 ± 0.34 3.06 ± 0.35 0.96 1.29 0.92
4 0.61 ± 0.09 0.48 ± 0.08 0.60 ± 0.09 0.63 ± 0.09 1.03 1.31 1.05
5FU 275.68 ± 17 258.46 ± 21 217.48 ± 19 258.46 ± 21 0.94 1.00 1.19
Cisplatin 230.41 ± 15 152.57 ± 14 207.51 ± 23 234.83 ± 19 1.02 1.54 1.13
[Ag(CN)2 5.13 ± 0.87 5.18 ± 0.93 5.08 ± 0.89 5.63 ± 0.96 1.10 1.09 1.11

*Values are given as the mean ± SD of three experiments and r2 = 0.91 to 0.98. Significant at P < 0.05.